“At the moment, I think we should forget about most of FAANG and focus on the financial centers. Oils. Large-scale retailers. Health insurers. Big pharmacy – and when I say big pharmacy, I mean just big pharmacy, absolutely not. “biotechnology, because they are the losers in an environment of high inflation,” said the presenter of “Mad Money”. The technology Nasdaq Composite fell 2.18% on Monday, while the Dow Jones Industrial Average fell 1.19%. The S&P 500 fell 1.69%. Cramer ‘s comments come after he said last week that investors should be conservative with FAANG shares as the market shifts to an environment that does not favor high – growth names.
CNBC Pro stock options and investment trends:
He added that investors should not sell all their technology development names, even if the market is not favorable for the stock in the short term. Investors with technology-laden portfolios should be strategically moving forward, he warned. “Those who have too much technology need a bounce to reposition themselves. I think you can do it.
